Ventas (VTR) to Release Earnings on Monday

Ventas (NYSE:VTR) will likely be posting its Q1 2026 results after the market closes on Monday, April 27th. Analysts expect Ventas to post earnings of $0.1229 per share and revenue of $1.5786 billion for the quarter. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Individuals may visit the the company’s upcoming Q1 2026 earning results page for the latest details on the call scheduled for Tuesday, April 28, 2026 at 10:00 AM ET.

Ventas (NYSE:VTR) last issued its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing the consensus estimate of $0.89 by ($0.74). Ventas had a return on equity of 2.09% and a net margin of 4.31%.The business had revenue of ($1,229.71) million during the quarter, compared to the consensus estimate of $1.53 billion. During the same quarter last year, the company earned $0.81 EPS. Ventas’s revenue for the quarter was up 21.7% on a year-over-year basis. On average, analysts expect Ventas to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Ventas Price Performance

Shares of NYSE:VTR opened at $83.75 on Friday. The firm’s 50 day moving average price is $84.70 and its 200-day moving average price is $79.51. Ventas has a twelve month low of $61.76 and a twelve month high of $88.36. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 1.03. The stock has a market capitalization of $39.82 billion, a PE ratio of 155.09, a price-to-earnings-growth ratio of 2.04 and a beta of 0.75.

Ventas Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st were paid a $0.52 dividend. This is a boost from Ventas’s previous quarterly dividend of $0.48. The ex-dividend date was Tuesday, March 31st. This represents a $2.08 annualized dividend and a dividend yield of 2.5%. Ventas’s dividend payout ratio (DPR) is currently 385.19%.

Insider Buying and Selling

In other Ventas news, CEO Debra A. Cafaro sold 10,322 shares of the firm’s stock in a transaction that occurred on Monday, February 2nd. The shares were sold at an average price of $77.66, for a total transaction of $801,606.52. Following the sale, the chief executive officer owned 1,114,034 shares in the company, valued at approximately $86,515,880.44. This trade represents a 0.92% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Carey S. Roberts sold 35,532 shares of the firm’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total transaction of $3,020,220.00. Following the sale, the executive vice president owned 72,755 shares in the company, valued at approximately $6,184,175. The trade was a 32.81% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.53% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Ventas

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. State Street Corp raised its stake in Ventas by 2.5% during the 4th quarter. State Street Corp now owns 29,662,635 shares of the real estate investment trust’s stock worth $2,309,234,000 after acquiring an additional 735,620 shares during the period. Price T Rowe Associates Inc. MD raised its stake in Ventas by 27.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 9,176,254 shares of the real estate investment trust’s stock worth $710,060,000 after acquiring an additional 2,000,341 shares during the period. Dimensional Fund Advisors LP raised its stake in Ventas by 5.1% during the 4th quarter. Dimensional Fund Advisors LP now owns 6,937,575 shares of the real estate investment trust’s stock worth $536,853,000 after acquiring an additional 336,432 shares during the period. Northern Trust Corp raised its stake in Ventas by 1.7% during the 3rd quarter. Northern Trust Corp now owns 6,402,941 shares of the real estate investment trust’s stock worth $448,142,000 after acquiring an additional 108,990 shares during the period. Finally, Morgan Stanley grew its holdings in Ventas by 19.9% during the 4th quarter. Morgan Stanley now owns 6,344,347 shares of the real estate investment trust’s stock valued at $490,926,000 after buying an additional 1,051,836 shares in the last quarter. Institutional investors own 94.18% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the stock. JPMorgan Chase & Co. increased their price objective on shares of Ventas from $88.00 to $93.00 and gave the stock an “overweight” rating in a research note on Friday, March 20th. KeyCorp increased their price objective on shares of Ventas from $85.00 to $90.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 10th. UBS Group reiterated a “neutral” rating and issued a $85.00 price objective on shares of Ventas in a research note on Monday, February 9th. Scotiabank increased their price objective on shares of Ventas from $80.00 to $93.00 and gave the stock a “sector perform” rating in a research note on Monday, March 2nd. Finally, Royal Bank Of Canada increased their price objective on shares of Ventas from $83.00 to $91.00 and gave the stock an “outperform” rating in a research note on Tuesday, February 10th. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, Ventas currently has a consensus rating of “Moderate Buy” and a consensus price target of $90.47.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.